Adopting MBMA with Clinical Outcome Database Powered by AI Technologies [Japanese Webinar]
Comparing your drug and the competition in terms of efficacy and safety data in the targeted therapeutic area is critically essential for optimizing development strategies and maximizing the value of a new drug. Model-based meta-analysis (MBMA) with clinical outcome database of publications and external information has been utilized to optimize trial design in recent years. … <a href="https://www.certara.com/webinar/adopting-mbma-with-clinical-outcome-database-powered-by-ai-technologies-japanese-webinar/">Continued</a>